Investigation of the ability of oral healthcare products containing Ardox-X® to combat oral malodour.
In this investigation, the clinical effectiveness of a series of two oral rinse products [Ardox-X® and Corsodyl oral rinses], each tested against a water placebo treatment, towards oral malodour (halitosis) was determined using a newly-developed, portable gas-chromatographic system with the ability to determine parts-per-billion (ppb) levels of 3 different VSCs in air directly sampled from the oral cavity. These VSC determinations were made before, and at selected diurnal time-points after treatment of participants with each of the oral rinse formulations in the recommended manner, and then compared with corresponding measurements made after they rinsed with a H2O placebo control in place of the oral rinse formulations.